Tumor Extracellular Vesicles lncOSLMT Drives Lung Inflammatory Premetastatic Niche Formation in Osteosarcoma via m 6 A‐Dependent hnRNPA2B1/COX‐2 Axis
Advanced Science · 2026
DOI: 10.1002/advs.202519490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Hongbo Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Osteosarcoma, Heterogeneous-Nuclear Ribonucleoprotein Group A-B, Cyclooxygenase 2, Extracellular Vesicles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Tumor‐derived extracellular vesicles (EVs) play critical roles in premetastatic niche (PMN) formation. Here, we demonstrated that EVs from highly metastatic osteosarcoma cell lines preferentially localized to lung fibroblasts and induce inflammatory PMN formation. High‐throughput profiling of EVs‐derived long noncoding RNAs (lncRNAs) identified lncOSLMT as a candidate enriched in EVs and markedly upregulated in patient tumors and serum, with elevated levels correlating with poor prognosis. Mechanistically, in EVs, lncOSLMT directly bound the RNA‐binding protein hnRNPA2B1. Following internalization by recipient lung fibroblasts, hnRNPA2B1 bound to N 6 ‐methyladenosine (m 6 A) ‐modified sites in the 3’UTR of PTGS2 mRNA, leading to transcript stabilization and increased COX‐2 expression. For therapeutic intervention, we developed lactoferrin‐resveratrol (LF‐RES) nanoparticles, which loaded siRNA against lncOSLMT. Intravenous administration of LF‐RES‐siRNA in mice reduced EVs‐induced lung inflammation and suppressed lung metastasis. Combination with EP2/EP4 antagonists produced enhanced anti‐metastatic effects. These findings establish EVs‐derived lncOSLMT as a key regulator of inflammatory PMN formation in the lung and highlight the potential of LF‐RES‐siRNA nanoparticles as a targeted anti‐metastatic therapy in osteosarcoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
- Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, Guangzhou, Guangdong, China.
- Department of Food Science and Nutrition, The Hong Kong Polytechnic University, Hong Kong, China.
- Department of Anesthesiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
ORCID-Profile: Xianbiao Xie
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Li, H., Guo, Z., Zou, Y., Zhang, J., Shi, J., Fu, X., Tu, J., Yao, H., Lu, X., Wen, L., & Xie, X. (2026). Tumor Extracellular Vesicles lncOSLMT Drives Lung Inflammatory Premetastatic Niche Formation in Osteosarcoma via m 6 A‐Dependent hnRNPA2B1/COX‐2 Axis. Advanced Science. https://doi.org/10.1002/advs.202519490
Vancouver
Li H, Guo Z, Zou Y, Zhang J, Shi J, Fu X, et al. Tumor Extracellular Vesicles lncOSLMT Drives Lung Inflammatory Premetastatic Niche Formation in Osteosarcoma via m 6 A‐Dependent hnRNPA2B1/COX‐2 Axis. Advanced Science. 2026. doi:10.1002/advs.202519490
BibTeX
@article{Li2026,
author = {Li, Hongbo and Guo, Zehao and Zou, Yutong and Zhang, Jiongfeng and Shi, Jixiang and Fu, Xihong and Tu, Jian and Yao, Hao and Lu, Xuanxuan and Wen, Lili and Xie, Xianbiao},
title = {Tumor Extracellular Vesicles lncOSLMT Drives Lung Inflammatory Premetastatic Niche Formation in Osteosarcoma via m 6 A‐Dependent hnRNPA2B1/COX‐2 Axis},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202519490}
}
EUVIMED